Biofil Chemicals and Pharmaceuticals Limited (NSE:BIOFILCHEM)

Market Cap	511.81M -28.6%
Revenue (ttm)	322.66M -20.6%
Net Income	27.73M +357.0%
EPS	1.70 +352.5%
Shares Out	n/a
PE Ratio	18.45
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,240
Average Volume	11,012
Open	31.77
Previous Close	31.77
Day's Range	31.77 - 32.14
52-Week Range	25.60 - 57.19
Beta	0.51
RSI	42.43
Earnings Date	May 30, 2026

About NSE:BIOFILCHEM

Biofil Chemicals and Pharmaceuticals Limited engages in manufacturing and trading of pharmaceuticals in India. It operates through Pharmaceutical and Chemical divisions. The company offers basic drugs and chemicals, such as sodium chloride, potassium chloride, sodium citrate, diethyl carbamazine citrate, ferrous sulphate, dried ferrous sulphate, ferrous fumerate, micro crystalline cellulose, and dicyclomine hydrochloride; and packaging solutions. It also provides job work service for manufacturing pharmaceutical drugs. Biofil Chemicals and Phar...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1985
• Employees: 26
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: BIOFILCHEM

Financial Performance

In fiscal year 2025, NSE:BIOFILCHEM's revenue was 335.82 million, a decrease of -16.89% compared to the previous year's 404.09 million. Earnings were 5.58 million, a decrease of -21.36%.